## EFX: Equifax Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 1.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($212.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Assenagon Asset Management S.A. Decreases Stock Holdings in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251227T000846 | Somewhat-Bearish | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in Equifax, Inc. (NYSE:EFX) by 94.5% in the third quarter, selling 49,030 shares and retaining 2,836 shares valued at $728,000. This comes amidst other institutional investors adjusting their positions and company insiders, including CEO Mark Begor, selling a total of 54,270 shares worth approximately $12.6 million in the last 90 days. Despite these sales, Equifax recently beat Q3 earnings estimates, issued strong FY2025 guidance, and holds a consensus "Moderate Buy" rating from analysts with an average target price of $274.73.

**2. Canoe Financial LP Buys 4,812 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251227T090811 | Somewhat-Bullish | Relevance: 100%
- Canoe Financial LP increased its stake in Equifax, Inc. (NYSE: EFX) by 60.8% in the third quarter, purchasing an additional 4,812 shares to now own 12,729 shares valued at $3.27 million. Despite high institutional ownership (96.20%), insiders have been net sellers, with the CEO and EVP recently offloading significant shares. Equifax surpassed Q3 EPS estimates and provided strong FY2025 guidance, leading to a consensus "Moderate Buy" rating from analysts with an average price target of $274.73 against a current trading price of approximately $220.56.

**3. Voya Investment Management LLC Trims Position in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251225T130759 | Neutral | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Equifax, Inc. by 44.5% in the third quarter of 2025, selling 21,803 shares and retaining 27,178 shares valued at approximately $6.97 million. This move comes as Equifax holds a consensus "Moderate Buy" rating from analysts with an average price target of $274.73, despite recent insider selling by executives. The article also details recent institutional trading activity, analyst upgrades/downgrades, and key financial performance indicators for Equifax.

**4. Equifax, Inc. $EFX Position Raised by ZWJ Investment Counsel Inc.**
- Source: MarketBeat | 20251225T133559 | Neutral | Relevance: 98%
- ZWJ Investment Counsel Inc. increased its stake in Equifax, Inc. (NYSE:EFX) by 18.4% in the third quarter, now holding 178,203 shares valued at $45.7 million. This comes despite recent insider selling, with executives offloading over $12 million in shares. Analysts maintain a "Moderate Buy" consensus rating for EFX, with an average price target of $274.73.

**5. Verisk (VRSK) Expands KYND Cyber Partnership: A Fresh Look at Whether the Stockâ€™s Valuation Still Stacks Up**
- Source: Simply Wall Street | 20251225T001210 | Neutral | Relevance: 64%
- Verisk Analytics (VRSK) has strengthened its cyber risk intelligence offerings by expanding its partnership with KYND, integrating richer data into its Rulebook platform, amid increasing UK retail cyber vulnerabilities. Despite this strategic move and double-digit earnings growth, Verisk's recent share price performance has been weak, even though a "Most Popular Narrative" suggests the stock is 12.9% undervalued. The article questions whether Verisk is a mispriced compounder or if its growth story is already fully factored into its valuation, noting its high P/E ratio compared to the industry average.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $280 | $290 | -3% |
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 8.1% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.02 suggests fair value with growth premium. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.02 |
| Forward P/E | 25.2 |
| Current P/E | 29.2 |
| YoY Growth | 16.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.9% to -0.3% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (0.92), confirming momentum. OFD pattern: +DLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.35% (CS: 65) | Neutral |
| RSI_14 | 61.1 | Neutral |
| MACD Histogram | 0.92 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.031x | Above |
| vs SMA200 | 0.919x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $222.03
- **Stop Loss:** $212.83 (4.1% risk)
- **Target:** $231.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $19,760.67
- **Portfolio %:** 19.76%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*